Leber Congenital Amaurosis (LCA)
An inherited retinal degenerative disease characterized by severe loss of vision at birth. Discover the mechanisms and the role of natural 9-cis beta-carotene.
Early Onset
Leber congenital amaurosis (LCA) is an inherited retinal degenerative disease characterized by severe loss of vision at birth. Infants often have sluggish pupil responses, nystagmus, and severe photophobia, pointing to retinal dysfunction.
Genetic Factors
LCA is linked to mutations in over 20 different genes. Key genes like RPE65 and LRAT are critical for the regeneration of the visual pigment. When impaired, the photoreceptors are starved of the chromophore necessary to perceive light.
9-cis Potential
Substantial studies indicate that 9-cis dietary supplementation can act as a substitute chromophore, artificially bypassing the impaired isomerase processes in models of LCA, highlighting its potential to dramatically improve retinal response.
Research Library
Access our curated database of clinical studies organized by health domain and year of publication.
Pharmacotherapy of retinal disease with visual cycle modulators.
9-cis-beta-carotene LCA research explores alternative chromophore therapy for Leber congenital amaurosis, offering potential oral treatment beyond gene therapy.
FDA Medical Disclaimer — These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Educational Purpose Only — The research and biomedical studies provided on this page are for informational and educational purposes only. They are intended to explain the mechanism of the 9-cis molecule. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.